With an estimated 1.6 million deaths worldwide annually, lung cancer is the leading cause of cancer death. However, progress is being made in improving the prevention, diagnosis and treatment of this malignancy. At the European Cancer Congress in Vienna, a substantial number of presentations reported encouraging results of early and late phase clinical trials in lung cancer. Below an impression of several of these studies.
(BELG J MED ONCOL 2015;9(:206–11)